TABLE OF CONTENTS
Volume 12, Issue 2 (February 2005)
Original Articles
Suppression of pancreatic tumor growth in the liver by systemic administration of the TRAIL gene driven by the hTERT promoter
Dietmar Jacob, John J Davis, Lidong Zhang, Hongbo Zhu, Fuminori Teraishi and Bingliang Fang
Cancer Gene Ther 12: 109-115; advance online publication, October 15, 2004; doi:10.1038/sj.cgt.7700773
Vascular administration of adenoviral vector soaked in absorbable gelatin sponge particles (GSP) prolongs the transgene expression in hepatocytes
Byeong-Ho Park, Jin-Hwa Lee, Jin-Sook Jeong, Seo-Hee Rha, Seung-Eun Kim, Jae-Seok Kim, Jeong-Man Kim and Tae-Ho Hwang
Cancer Gene Ther 12: 116-121; advance online publication, December 3, 2004; doi:10.1038/sj.cgt.7700744
Intratumoral administration of immature dendritic cells following the adenovirus vector encoding CD40 ligand elicits significant regression of established myeloma
Yongqing Liu, Dajing Xia, Fang Li, Changyu Zheng and Jim Xiang
Cancer Gene Ther 12: 122-132; advance online publication, November 26, 2004; doi:10.1038/sj.cgt.7700757
Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer
Geng-Feng Fu, Xi Li, Ya-Yi Hou, Yan-Rong Fan, Wen-Hua Liu and Gen-Xing Xu
Cancer Gene Ther 12: 133-140; advance online publication, November 26, 2004; doi:10.1038/sj.cgt.7700758
Replication-selective oncolytic viruses in the treatment of cancer
Bart Everts and Henk G van der Poel
Cancer Gene Ther 12: 141-161; advance online publication, October 8, 2004; doi:10.1038/sj.cgt.7700771
Employment of microarray analysis to characterize biologic differences associated with tropism-modified adenoviral vectors: utilization of non-native cellular entry pathways
Andrea L Volk, Angel A Rivera, Grier P Page, Jesus F Salazar-Gonzalez, Dirk M Nettelbeck, Qiana L Matthews and David T Curiel
Cancer Gene Ther 12: 162-174; advance online publication, September 17, 2004; doi:10.1038/sj.cgt.7700776
Systemic administration of attenuated Salmonella choleraesuis carrying thrombospondin-1 gene leads to tumor-specific transgene expression, delayed tumor growth and prolonged survival in the murine melanoma model
Che-Hsin Lee, Chao-Liang Wu and Ai-Li Shiau
Cancer Gene Ther 12: 175-184; advance online publication, September 17, 2004; doi:10.1038/sj.cgt.7700777
Depletion of CD25+ cells from human T-cell enriched fraction eliminates immunodominance during priming with dendritic cells genetically modified to express a secreted protein
Milcho Mincheff, Serguei Zoubak, Iskra Altankova, Stoyan Tchakarov, Petro Pogribnyy, Yevgen Makogonenko, Chavdar Botev and Harold T Meryman
Cancer Gene Ther 12: 185-197; advance online publication, September 17, 2004; doi:10.1038/sj.cgt.7700778
Bypassing tumor-associated immune suppression with recombinant adenovirus constructs expressing membrane bound or secreted GITR-L
Bastien Calmels, Stéphane Paul, Nicolas Futin, Catherine Ledoux, Fabienne Stoeckel and Bruce Acres
Cancer Gene Ther 12: 198-205; advance online publication, October 8, 2004; doi:10.1038/sj.cgt.7700781
Suppression of peritoneal implantation of gastric cancer cells by adenovirus vector-mediated NK4 expression
Hitoshi Fujiwara, Takeshi Kubota, Hisashi Amaike, Satoshi Inada, Kazuhiro Takashima, Kiyoto Atsuji, Mamoru Yoshimura, Makoto Maemondo, Ko Narumi, Toshihiro Nukiwa, Kunio Matsumoto, Toshikazu Nakamura, Akeo Hagiwara and Hisakazu Yamagishi
Cancer Gene Ther 12: 206-216; advance online publication, October 15, 2004; doi:10.1038/sj.cgt.7700782
